Remission rates increase substantially by adding Adalimumab to Methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis - 1-year results of investigator-initiated, dobuleblinded randomized clinical trial (OPERA)

Hørslev-Petersen, K. (Foredragsholder)

Aktivitet: Foredrag og mundtlige bidragForedrag og præsentationer i privat eller offentlig virksomhed

Periode2. sep. 2012
Sted for afholdelseScandinavian Congress of Rheumatology
BegivenhedstypeKonference
Konferencenummer34
PlaceringCopenhagen, Danmark